Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07132957 | A Study of AL8326 in Healthy Subjects | completed | Phase 1 | 6 | Advenchen Laboratories Nanjing Ltd.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT04951154 | A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer | completed | — | 33 | Janssen Research & Development, LLCINDUSTRY | 1 | Aug 19, 2025 | clinicaltrials |
| NCT01951482 | Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer | completed | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT06141005 | Feasibility of Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Lung Cancer | completed | N/A | 65 | Pusan National University HospitalOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT02327078 | A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) | completed | Phase 1 / Phase 2 | 307 | Incyte CorporationINDUSTRY | 2 | Aug 14, 2025 | clinicaltrials |
| NCT02623712 | The Watch the Spot Trial(WTS) | completed | N/A | 34,686 | Kaiser PermanenteOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT07121387 | A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer | completed | — | 221 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT02475213 | Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer | completed | Phase 1 | 146 | MacroGenicsINDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT04206072 | D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC | completed | Phase 2 / Phase 3 | 362 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05645731 | Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study | completed | — | 100 | Nicole Ezer, MD, FRCPC, MPHOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT03721120 | Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer(LIBELULE) | completed | N/A | 319 | Centre Leon BerardOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT04825834 | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)(DELFI-L101) | completed | — | 2,992 | Delfi Diagnostics Inc.INDUSTRY | 2 | Aug 8, 2025 | clinicaltrials |
| NCT07111104 | Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma(ARIS) | completed | — | 350 | Hopitaux Prives de Metz, Groupe UNEOSOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT02681549 | Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Yale UniversityOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05585034 | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | completed | Phase 1 | 60 | Xencor, Inc.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07065422 | AI Models for Predicting Occult Pleural Dissemination in NSCLC | completed | — | 326 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07107893 | Comparison of Double Lumen Tube Location Verification Techniques in Single Lung Ventilation | completed | — | 93 | Kayseri City HospitalOTHER_GOV | 1 | Aug 6, 2025 | clinicaltrials |
| NCT02903914 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | completed | Phase 1 | 260 | Incyte CorporationINDUSTRY | 4 | Aug 5, 2025 | clinicaltrials |
| NCT05253807 | Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration(FIGHT-210) | completed | Phase 2 | 8 | Incyte CorporationINDUSTRY | 5 | Aug 5, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06617390 | A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments(RECAP) | completed | — | 1,041 | Daiichi SankyoINDUSTRY | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07100444 | Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival | completed | — | 139 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT00243867 | Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer | completed | Phase 3 | 518 | American Regent, Inc.INDUSTRY | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05212285 | Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer | completed | — | 469 | Fudan UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07099105 | Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer(SP vs MP robot) | completed | — | 339 | Korea University Guro HospitalOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05993273 | Pain Control After VATS Anatomical Pulmonary Resections | completed | N/A | 75 | University Hospital PadovaOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06544200 | Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection | completed | N/A | 104 | University Hospital PadovaOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT00199615 | Follow-up of Patients With Curative-intent Surgical Resection for NSCLC | completed | N/A | 73 | University Hospital, LimogesOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT04830826 | A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China(ADDRESS) | completed | — | 1,490 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05292859 | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | completed | — | 7 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05303493 | Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma | completed | Phase 1 | 45 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT02769832 | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | completed | Phase 2 | 32 | Muhammad FurqanOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT02392455 | VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC) | completed | — | 817 | Boehringer IngelheimINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04051827 | Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 26 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Jul 28, 2025 | clinicaltrials |
| NCT00284778 | Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 150 | University Hospital, LimogesOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT04026412 | A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery(CheckMate73L) | completed | Phase 3 | 925 | Bristol-Myers SquibbINDUSTRY | 27 | Jul 24, 2025 | clinicaltrials |
| NCT06602674 | PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions | completed | — | 647 | Ruijin HospitalOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) | completed | — | 206 | Pierre Fabre MedicamentINDUSTRY | 5 | Jul 22, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT00199758 | Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 227 | University Hospital, LimogesOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05651867 | EPIONE Guided Lung Evaluation(EGLE) | completed | N/A | 25 | Quantum SurgicalINDUSTRY | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04242199 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors | completed | Phase 1 | 182 | Incyte CorporationINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT03131037 | Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer | completed | Phase 1 | 12 | Candel Therapeutics, Inc.INDUSTRY | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04120454 | Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 6 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT02611024 | Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | completed | Phase 1 / Phase 2 | 316 | PharmaMarINDUSTRY | 6 | Jul 9, 2025 | clinicaltrials |
| NCT07055997 | Robotic-Assisted Navigation for Lung Nodule Localization: A Non-Inferiority Study | completed | N/A | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07000721 | Research on New Diagnosis and Treatment Technologies for Early Lung Cancer | completed | N/A | 92 | Jisong ZhangOTHER | 1 | Jul 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 20, 2025source: clinicaltrials